97844288

Information

• Trademark
• 97844288

• Source

• Serial Number

  97844288

• Registration Number

  7635116

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 17, 2023
  2 years ago

• Registration Date

  December 31, 2024
  10 months ago

• Transaction Date

  December 31, 2024
  10 months ago

• Status Date

  December 31, 2024
  10 months ago

• Published for Opposition Date

  January 30, 2024
  a year ago

• Location Date

  December 09, 2024
  11 months ago

• First Use Anywhere Date

  May 12, 2021
  4 years ago

• First Use In Commerce Date

  May 12, 2021
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  STOIDES, KATHERINE

• Attorney Docket Number

  16187.0005

  Attorney Name

  Danny M. Awdeh

  Law Office Assigned Location Code

  L10

• Owners

  • CRINETICS PHARMACEUTICALS, INC.

Case File Statements

• DM0000: The mark consists of dot and line spirograph design in the shape of a half circle.
• GS0051: Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine related diseases; pharmaceutical preparations for targeting neuropeptide receptors; pharmaceutical preparations for the treatment of cancer, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, carcinoid syndrome, congenital adrenal hyperplasia, hypercalcemia, chronic pain, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic preparations for the treatment of ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders
• GS0421: Medical research services; scientific research and development; pharmaceutical research and development; therapeutic research and development, namely, research and development of therapeutic preparations; research and development in the field of oncology; medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; pharmaceutical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic research, namely, research of therapeutic preparations for ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and therapeutics

Case File Event Statements

• 3/21/2023 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/9/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/11/2023 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 10/9/2023 - 2 years ago

  4 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 10/9/2023 - 2 years ago

  11 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 12/13/2023 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 12/18/2023 - a year ago

  6 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/18/2023 - a year ago

  7 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/18/2023 - a year ago

  8 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/19/2023 - a year ago

  9 - ASSIGNED TO LIE Type: ALIE

• 12/19/2023 - a year ago

  10 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/22/2023 - a year ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/10/2024 - a year ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/30/2024 - a year ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/30/2024 - a year ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/26/2024 - a year ago

  19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 9/12/2024 - a year ago

  24 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 9/12/2024 - a year ago

  20 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/28/2024 - a year ago

  16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 2/28/2024 - a year ago

  17 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/28/2024 - a year ago

  18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 9/12/2024 - a year ago

  26 - USE AMENDMENT FILED Type: IUAF

• 9/12/2024 - a year ago

  23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/12/2024 - a year ago

  21 - SOU EXTENSION 1 FILED Type: EXT1

• 9/12/2024 - a year ago

  22 - SOU EXTENSION 1 GRANTED Type: EX1G

• 11/13/2024 - 12 months ago

  27 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 11/13/2024 - 12 months ago

  25 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 12/9/2024 - 11 months ago

  28 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 12/9/2024 - 11 months ago

  29 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 12/31/2024 - 10 months ago

  30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/31/2024 - 10 months ago

  31 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC